| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
Departments of Endocrinology (M.Á.G.-L., M.M.) and Immunology (D.S., F.S.-M.), Hospital de la Princesa, Universidad Autónoma, Madrid 28006, Spain
Address all correspondence and requests for reprints to: Dr. Monica Marazuela, Servicio de Endocrinología, Hospital de la Princesa, Diego de León 62, Madrid 28006, Spain. E-mail: mmarazuela{at}hlpr.insalud.es
Abstract
To better understand the selective migration of lymphocytes in
autoimmune thyroid disorders (AITDs), we analyzed thyroid samples and
demonstrated an enhanced expression of the chemokines interferon
(IFN)-inducible protein (Ip)-10 and regulated on activation normal T
lymphocyte expressed and secreted (RANTES) in thyroids from AITD
patients. Ip-10 and monokine induced by IFN-
(Mig) were expressed
in vivo in thyroid follicular cells (TFCs) from AITD
thyroids. Interestingly, Ip-10 mRNA, although not basally detected in
cultured TFCs, was strongly induced by IFN-
and synergistically
increased by TNF-
addition. Furthermore, high levels of Ip-10
protein were detected in the supernatants of IFN-
-stimulated TFCs.
Likewise, Mig protein was strongly induced in TFCs by the same stimuli
as Ip-10. Unlike Ip-10 and Mig, the expression of RANTES was induced
mainly by TNF-
. In addition, intrathyroidal lymphocytes from
AITD patients showed higher expression of CXCR3, CCR2, and CCR5
chemokine receptors than autologous peripheral blood lymphocytes. T
lymphoblasts expressing CXCR3 showed an increased migration to
supernatants from stimulated TFCs, which was abolished by specific
antibodies to the chemokines Ip-10 and Mig, as well as to their
receptor CXCR3. Taken together, these data suggest a potential role of
TFCs, through the production of the chemokines Ip-10, Mig and RANTES,
in regulating the recruitment of specific subsets of activated
lymphocytes in AITDs.
This article has been cited by other articles:
![]() |
E. Borgogni, E. Sarchielli, M. Sottili, V. Santarlasci, L. Cosmi, S. Gelmini, A. Lombardi, G. Cantini, G. Perigli, M. Luconi, et al. Elocalcitol Inhibits Inflammatory Responses in Human Thyroid Cells and T Cells Endocrinology, July 1, 2008; 149(7): 3626 - 3634. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Crescioli, L Cosmi, E Borgogni, V Santarlasci, S Gelmini, M Sottili, E Sarchielli, B Mazzinghi, M Francalanci, A Pezzatini, et al. Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes J. Endocrinol., October 1, 2007; 195(1): 145 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rotondi, L. Chiovato, S. Romagnani, M. Serio, and P. Romagnani Role of Chemokines in Endocrine Autoimmune Diseases Endocr. Rev., August 1, 2007; 28(5): 492 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Inukai, A. Momobayashi, N. Sugawara, and Y. Aso Changes in expression of T-helper (Th) 1- and Th2-associated chemokine receptors on peripheral blood lymphocytes and plasma concentrations of their ligands, interferon-inducible protein-10 and thymus and activation-regulated chemokine, after antithyroid drug administration in hyperthyroid patients with Graves' disease Eur. J. Endocrinol., June 1, 2007; 156(6): 623 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rotondi, R. Minelli, F. Magri, P. Leporati, P. Romagnani, M. C. Baroni, R. Delsignore, M. Serio, and L. Chiovato Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-{alpha} therapy for hepatitis C virus-related hepatitis Eur. J. Endocrinol., April 1, 2007; 156(4): 409 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Antonelli, M. Rotondi, P. Fallahi, M. Grosso, G. Boni, S. M. Ferrari, P. Romagnani, M. Serio, G. Mariani, and E. Ferrannini Iodine-131 Given for Therapeutic Purposes Modulates Differently Interferon-{gamma}-Inducible {alpha}-Chemokine CXCL10 Serum Levels in Patients with Active Graves' Disease or Toxic Nodular Goiter J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1485 - 1490. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Koida, K. Tsukasaki, T. Tsuchiya, H. Harasawa, T. Fukushima, Y. Yamada, K. Ohshima, S. Kamihira, M. Kikuchi, and M. Tomonaga Primary T-cell lymphoma of the thyroid gland with chemokine receptors of Th1 phenotype complicating autoimmune thyroiditis Haematologica, March 1, 2007; 92(3): e37 - e40. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Marazuela, M. A. Garcia-Lopez, N. Figueroa-Vega, H. de la Fuente, B. Alvarado-Sanchez, A. Monsivais-Urenda, F. Sanchez-Madrid, and R. Gonzalez-Amaro Regulatory T Cells in Human Autoimmune Thyroid Disease J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3639 - 3646. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Antonelli, P. Fallahi, M. Rotondi, S. M. Ferrari, P. Romagnani, M. Grosso, E. Ferrannini, and M. Serio Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process. Eur. J. Endocrinol., May 1, 2006; 154(5): 651 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Antonelli, M. Rotondi, S. M. Ferrari, P. Fallahi, P. Romagnani, S. S. Franceschini, M. Serio, and E. Ferrannini Interferon-{gamma}-Inducible {alpha}-Chemokine CXCL10 Involvement in Graves' Ophthalmopathy: Modulation by Peroxisome Proliferator-Activated Receptor-{gamma} Agonists J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 614 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chen, Y. Wei, A. Alter, G. C. Sharp, and H. Braley-Mullen Chemokine expression during development of fibrosis versus resolution in a murine model of granulomatous experimental autoimmune thyroiditis J. Leukoc. Biol., September 1, 2005; 78(3): 716 - 724. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Harii, C. J. Lewis, V. Vasko, K. McCall, U. Benavides-Peralta, X. Sun, M. D. Ringel, M. Saji, C. Giuliani, G. Napolitano, et al. Thyrocytes Express a Functional Toll-Like Receptor 3: Overexpression Can Be Induced by Viral Infection and Reversed by Phenylmethimazole and Is Associated with Hashimoto's Autoimmune Thyroiditis Mol. Endocrinol., May 1, 2005; 19(5): 1231 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Aust, M Kamprad, P Lamesch, and E Schmucking CXCR6 within T-helper (Th) and T-cytotoxic (Tc) type 1 lymphocytes in Graves' disease (GD) Eur. J. Endocrinol., April 1, 2005; 152(4): 635 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rotondi, A. Falorni, A. De Bellis, S. Laureti, P. Ferruzzi, P. Romagnani, A. Buonamano, E. Lazzeri, C. Crescioli, M. Mannelli, et al. Elevated Serum Interferon-{gamma}-Inducible Chemokine-10/CXC Chemokine Ligand-10 in Autoimmune Primary Adrenal Insufficiency and in Vitro Expression in Human Adrenal Cells Primary Cultures after Stimulation with Proinflammatory Cytokines J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2357 - 2363. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Antonelli, M. Rotondi, P. Fallahi, P. Romagnani, S. M. Ferrari, A. Paolicchi, E. Ferrannini, and M. Serio Increase of interferon-{gamma} inducible {alpha} chemokine CXCL10 but not {beta} chemokine CCL2 serum levels in chronic autoimmune thyroiditis Eur. J. Endocrinol., February 1, 2005; 152(2): 171 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Antonelli, M. Rotondi, P. Fallahi, P. Romagnani, S. M. Ferrari, A. Buonamano, E. Ferrannini, and M. Serio High Levels of Circulating CXC Chemokine Ligand 10 Are Associated with Chronic Autoimmune Thyroiditis and Hypothyroidism J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5496 - 5499. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Martin, E. C. Coronel, G.-i. Sano, S.-C. Chen, G. Vassileva, C. Canasto-Chibuque, J. D. Sedgwick, P. S. Frenette, M. Lipp, G. C. Furtado, et al. A Novel Model for Lymphocytic Infiltration of the Thyroid Gland Generated by Transgenic Expression of the CC Chemokine CCL21 J. Immunol., October 15, 2004; 173(8): 4791 - 4798. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Patterson, J. K. Daley, L. A. Echols, T. E. Lane, and G. F. Rall Measles Virus Infection Induces Chemokine Synthesis by Neurons J. Immunol., September 15, 2003; 171(6): 3102 - 3109. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Romagnani, M. Rotondi, E. Lazzeri, L. Lasagni, M. Francalanci, A. Buonamano, S. Milani, P. Vitti, L. Chiovato, M. Tonacchera, et al. Expression of IP-10/CXCL10 and MIG/CXCL9 in the Thyroid and Increased Levels of IP-10/CXCL10 in the Serum of Patients with Recent-Onset Graves' Disease Am. J. Pathol., July 1, 2002; 161(1): 195 - 206. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |